Joel M Gelfand, MD MSCE
James J. Leyden, M.D. Endowed Professor in Clinical Investigation
Associate Fellow, Center for Public Health Initiatives, University of Pennsylvania
Senior Scholar, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania
Medical Director, Psoriasis and Phototherapy Treatment Center, Department of Dermatology, University of Pennsylvania
Endowed Professorship, James J. Leyden, M.D. Endowed Professorship in Clinical Investigation
Director, Center for Clinical Sciences in Dermatology
Department: Dermatology
Graduate Group Affiliations
Contact information
Perelman Center for Advanced Medicine
7th Floor, South Tower
Suite 730
Philadelphia, PA 19104
7th Floor, South Tower
Suite 730
Philadelphia, PA 19104
Links
Faculty Website
Dr. Gelfand Clinical Research Lab
Dermatology Clinical Effectiveness Research Network (DCERN)
Faculty Website
Dr. Gelfand Clinical Research Lab
Dermatology Clinical Effectiveness Research Network (DCERN)
Education:
B.S. (Biology, Community Health)
Tufts University, 1993.
M.D.
Harvard Medical School, 1998.
M.S.C.E. (Epidemiology)
University of Pennsylvania, 2003.
Permanent linkB.S. (Biology, Community Health)
Tufts University, 1993.
M.D.
Harvard Medical School, 1998.
M.S.C.E. (Epidemiology)
University of Pennsylvania, 2003.
Description of Other Expertise
DermatologySelected Publications
Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, and Troxel AB: The risk of myocardial infarction in patients with psoriasis. Journal of the American Medical Association 296: 1735-1741, 2006.Gelfand JM, Gladman DD, Mease PJ, Smith N, Margolis DJ, Nijsten T, Stern RS, Feldman SR, Rolstad T: Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 53(4): 573, Oct 2005.
Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB: The risk of lymphoma in patients with psoriasis. J Invest Dermatol 126(10): 2194-201, Oct 2006.
Gelfand JM, Dommasch E, Shin DB, Azfar RS, Kurd SK, Wang X, Troxel AB: The risk of stroke in patients with psoriasis. J Invest Determatol 129(10): 2411-8, Oct 2009.
Mehta NN, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM: Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database. Eur Heart J 31(8): 1000-6, Apr 2010.
Dommasch, ED, Abuabara, K, Shin, DB, Nguyen, J, Troxel, AB, Gelfand JM. : The risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials. J Am Acad Dermatol 64(6): 1035-50, Jun 2011.
Mehta N, Yu YD, Saboury B, Foroughi N, Krishnamoorthy P, Raper A, Baer A, Antigua J, Van Voorhees AS, Torigian DA, Alavi A, Gelfand JM: Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol 147(9): 1031-9, Sep 2011.
Langan SM, Seminara, NM, Shin, DB, Troxel A, Kimmel SE, Mehta NN, Margolis DJ, Gelfand JM: Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 132(3Pt1): 556-62, Mar 2012.
Gelfand JM, Wan J, Callis Duffin, K, Krueger GG, Kalb RE, Weisman JD, Sperber BR, Stierstorfer MB, Brod BA, Schleicher SM, Bebo BF, Troxel AB, Shin DB, Steinemann JM, Goldfarb J, Yeung H, Van Voorhees AS: Comparative effectiveness of commonly used systemic treatments or phototherapy for moderate to severe plaque psoriasis in the clinical practice setting. Arch Dermatol 148(4): 487-94, Apr 2012.
Azfar AS, Seminara NM, Shin DB, Troxel AB, Margolis DJ, Gelfand JM: Increased risk of diabetes mellitus and likelihood of receiving diabetes mellitus treatment in patients with psoriasis. Arch Dermatol 148(9): 995-1000, Sep 2012.
Mehta NN, Torigian DA, Gelfand, JM, Saboury, B, Alavi A: Quantification of atherosclerotic plaque activity and vascular inflammation using [18-F] fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). J Vis Exp 63: e3777, May 2012.
Yeung H, Wan J, Van Voorhees AS, Callis Duffin K, Kreuger GG, Kalb RE, Weisman JD, Sperber BR, Brod BA, Bebo F, Schleicher SM, Shin DB, Troxel AB, Gelfand JM: Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis. J Am Acad Dermatol 68(1): 64-72, Jan 2013.